Quality of Life and Diagnostic Considerations for FCS

Opinion
Video

Panelists discuss how familial chylomicronemia syndrome (FCS) imposes a significant economic burden on patients, affecting their ability to stay employed and manage the costs associated with long-term care and treatment.

Video content above is prompted by the following:

What economic burden does familial chylomicronemia syndrome have on patients?

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.